Stason Pharmaceuticals, Inc. is a fully-integrated cGMP contract development organization providing complete turn-key drug development services for oral products. We offer services for both non-High Containment and High Containment Products. Stason offers a range of services for New Chemical Entities, generics, and upgrades to existing formulations, and provides development and manufacturing services in its FDA inspected facilities. We currently produce finished products at all scales through to commercial scale.
Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016 The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.
James E. Gregory, UPM Pharmaceuticals||October 7, 2015 Pharmaceutical and biopharmaceutical companies large and small are increasingly relying on third-party providers for support at all stages of drug development. To realize efficiencies, they are at the same time reducing the number of suppliers to a preferred few with whom they can form strategic partnerships.
Franklin Spriggs, Stephanie Mowery and Bo Kowalcyk, AIT Bioscience ||October 7, 2015 ADCs are a breakthrough cancer treatment that can deliver cytotoxins directly to cancer cells without the sweeping collateral damage of traditional chemotherapy.